New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 18, 2014
09:07 EDTENZEnzo Biochem announces agreement to market HER-2/neu serum test
Enzo Biochem announced that its Enzo Clinical Labs subsidiary and Massachusetts-based Nuclea Biotechnologies, have entered into a non-exclusive distribution agreement to market Nuclea’s non-invasive HER-2/neu serum test, a key assay in the monitoring of metastatic breast cancer. The test measures the portion of HER-2/neu protein that lies outside the surface of the cell and being released into the blood stream, allowing for more informed treatment decisions for a number of women who may not be responding to breast cancer treatment or may be at risk for metastatic cancer and need revised treatment plans.
News For ENZ From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 9, 2014
16:19 EDTENZEnzo Biochem reports Q4 EPS (7c), one estimate (7c)
Subscribe for More Information
October 7, 2014
09:02 EDTENZEnzo awarded patent covering gene therapy treatment for cancers
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use